Success Metrics

Clinical Success Rate
84.6%

Based on 11 completed trials

Completion Rate
85%(11/13)
Active Trials
0(0%)
Results Posted
100%(11 trials)
Terminated
2(13%)

Phase Distribution

Ph early_phase_1
1
7%
Ph phase_3
7
47%
Ph phase_4
3
20%
Ph not_applicable
2
13%
Ph phase_1
1
7%

Phase Distribution

2

Early Stage

0

Mid Stage

10

Late Stage

Phase Distribution14 total trials
Early Phase 1First-in-human
1(7.1%)
Phase 1Safety & dosage
1(7.1%)
Phase 3Large-scale testing
7(50.0%)
Phase 4Post-market surveillance
3(21.4%)
N/ANon-phased studies
2(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.6%

11 of 14 finished

Non-Completion Rate

21.4%

3 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Completed(11)
Terminated(3)
Other(1)

Detailed Status

Completed11
Terminated2
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
84.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (7.1%)
Phase 11 (7.1%)
Phase 37 (50.0%)
Phase 43 (21.4%)
N/A2 (14.3%)

Trials by Status

terminated213%
withdrawn17%
completed1173%
unknown17%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT00584246Phase 4

Pregabalin (Lyrica) for the Treatment of Restless Legs Syndrome

Withdrawn
NCT00646451Early Phase 1

Pregabalin in the Treatment of Essential Tremor

Completed
NCT00468845Phase 3

Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo For Treatment Of Post-Surgical Pain From Hysterectomy

Completed
NCT00654940Phase 1

A Study To Assess The Ability Of A Crossover Study Design To Detect The Efficacy Of Pregabalin In Post-Traumatic Neuropathic Pain Patients

Completed
NCT01145417Phase 3

Pregabalin Trial In HIV Neuropathic Pain

Terminated
NCT01727791Phase 4

A Study Of Pregabalin (Lyrica) Drug Levels In Urine, Plasma And Breast Milk Of Healthy Lactating Women

Completed
NCT01020474Phase 4

Adolescent Fibromyalgia Study

Completed
NCT00372528Phase 3

An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures

Terminated
NCT00830128Phase 3

A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin In Patients With Fibromyalgia

Completed
NCT01220180

Lyrica (Pregabalin) Korean Post Marketing Surveillance Study

Completed
NCT00219544Phase 3

Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain.

Completed
NCT00631943Phase 3

A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain

Completed
NCT01057693Phase 3

Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy

Completed
NCT03530280Not Applicable

Effect of Pregabalin or Adductor Canal Block on Postoperative Analgesia

Completed
NCT01370915Not Applicable

Perioperative Administration of Pregabalin for Pain After Septoplasty

Unknown

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15